Related Experiment Video
Updated: Jul 14, 2026

The Use of Cystometry in Small Rodents: A Study of Bladder Chemosensation
Published on: August 21, 2012
Anticholinergics [corrected] in patients with overactive bladder: Assessment of ambulatory urodynamics and patient
Seung-June Oh1, Hwancheol Son, Jeong Yun Jeong
1Department of Urology, Seoul National University College of Medicine, Seoul, Korea.
Aims:
The aim of this study was to evaluate whether ambulatory urodynamic monitoring (AUM) may reflect patient perception of bladder condition and treatment benefit in patients with overactive bladder (OAB).
Methods:
A total of 33 women and 7 men 23 to 72 years old who were undergoing AUM were included in this study. At baseline, patients were asked to complete the following information in the micturition chart for 3 consecutive days. Patients were given anticholinergics once daily for the 2 weeks. Two weeks after the treatment, all patients received an identical repeat study.
Results:
Most parameters of AUM, micturition chart and patient perception were improved 2 weeks after treatment. However, when Spearman correlation coefficients were performed, all AUM parameters did not correlate with patient perception of bladder condition after treatment although some AUM parameters regarding incontinence were associated with patient perception of bladder condition at baseline. In addition, when patients were divided as the 'no or some benefit' group (n = 25) and the 'much benefit' group (n = 15), all AUM parameters except total voided volume (P = 0.004) were not significantly different in the two groups.
Conclusions:
Because patients with pelvic floor dysfunction have widely varying expectations from treatment, the patient's goal for treatment is highly subjective. Our findings suggest that AUM does not take into account the patient perception of disease severity, and correlations between the patient view of treatment outcome and objective measures are poor. Therefore, strategies for assessing OAB should incorporate self-perceived disease condition.
Related Concept Videos
Cholinergic Antagonists: Therapeutic Uses
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Cholinergic Antagonists: Pharmacokinetics
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Cholinergic Antagonists: Pharmacological Actions
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Urodynamic Studies: Uroflowmetry
Direct-Acting Cholinergic Agonists: Pharmacological Actions
